Search

Your search keyword '"Davide Pastorelli"' showing total 2 results
Start Over Author "Davide Pastorelli" Publisher omics publishing group
2 results on '"Davide Pastorelli"'

1. Good and Prolonged Response to Low Dose Capecitabine as Second Line Therapy in a Patient with Advanced Hepatocellular Carcinoma

Author

Davide Pastorelli, Giuseppe Lombardi, Silvano Fasolato, Paolo Angeli, Caterina Soldà, and Camillo Aliberti

Subjects
Oncology, Sorafenib, medicine.medical_specialty, Cirrhosis, business.industry, Low dose, Context (language use), General Medicine, Pharmacology, medicine.disease, digestive system diseases, Capecitabine, Clinical trial, Hepatocellular carcinoma, Internal medicine, medicine, Liver function, business, neoplasms, medicine.drug
Abstract

Sorafenib is the only validated pharmacological treatment option for patients with advanced hepatocellular carcinoma (HCC) in the context of Child-Pugh class A liver function. Effective and safe systemic treatments for advanced disease with severe underlying cirrhosis (Child-Pugh class B and C) are not yet available. A few reports have described capecitabine as an option after failure of sorafenib or for patients who were not eligible for clinical trials. Here, we present a case of good response to low dose capecitabine in a patient with advanced HCC.

Published
2015
Full Text
View/download PDF

2. Chemotherapy-Induced Nausea and Vomiting (CINV): the Achilles’ Heel of Oncologists

Author

Davide Pastorelli and C. Soldà

Subjects
Antiemetic Drugs, medicine.medical_specialty, Chemotherapy, Heel, Cancer chemotherapy, business.industry, Nausea, medicine.drug_class, medicine.medical_treatment, General Medicine, humanities, Surgery, medicine.anatomical_structure, Anesthesia, Vomiting, Medicine, Antiemetic, medicine.symptom, business, Chemotherapy-induced nausea and vomiting
Abstract

The incidence of chemotherapy-induced nausea and vomiting (CINV) has been decreasing through improvements of antiemetic drugs and refinements of antiemetic guidelines. However,CINV still occurs in approximately half of patients receiving cancer chemotherapy .

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results